Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor.

Pretreatment with a low dose of recombinant human interleukin-1 beta (IL-1) (3 to 30 micrograms/kg) 24 h before a lethal Pseudomonas aeruginosa infection prolongs survival in neutropenic mice. We investigated the role of the type I IL-1 receptor (IL-1RI) and IL-1RII in this IL-1-induced protection b...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Vogels, M T, Eling, W M, Otten, A, van der Meer, J W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162819/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7486912/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.8.1744
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!